Finance

Beta
Lists
IMNN:NASDAQ
Imunon Inc
$2.06
-1.90%
(-0.040) 1D
Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMNN...
Open
$2.17
High
$2.18
Low
$2.05
Mkt. cap
8.66M
Avg. vol.
46.80K
Volume
39.00
52-wk high
$27.65
52-wk low
$2.04
EPS
-$5.74
Beta
1.94
Shares outstanding
4.20M
No. of employees
20
Open
$2.17
High
$2.18
Low
$2.05
Mkt. cap
8.66M
Avg. vol.
46.80K
Volume
39.00
52-wk high
$27.65
52-wk low
$2.04
EPS
-$5.74
Beta
1.94
Shares outstanding
4.20M
No. of employees
20
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to IMNN in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for IMNN in the last 3 months.
Highest
Current $2.06
$25.00 (+1,113.59%)
Average
$15.67 (+660.68%)
Lowest
$10.00 (+385.44%)
News stories
From sources across the web
About Imunon Inc
CEO-
Employees20
Founded1982
Headquarters-
SectorBiotechnology
Websiteimunon.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
1.23M
-
-
-
Cost of revenue
1.23M
-
-
-
Research and development expenses
-
1.90M
2.49M
2.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.54M
1.58M
1.77M
1.97M
Operating expense
1.54M
3.48M
4.26M
4.31M
Total operating expenses
2.77M
3.48M
4.26M
4.31M
Operating income
-2.77M
-3.48M
-4.26M
-4.31M
Other non operating income
-
-
-
-
EBT including unusual items
-2.74M
-3.43M
-4.22M
-4.25M
EBT excluding unusual items
-2.74M
-3.43M
-4.22M
-4.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.74M
-3.43M
-4.22M
-4.25M
Net profit margin
-
-
-
-
Earnings per share
-1.87
-1.16
-1.30
-0.84
Interest and investment income
27.30K
46.70K
38.85K
58.00K
Interest expense
-
-
-
-
Net interest expenses
27.30K
46.70K
38.85K
58.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.69M
-3.40M
-4.19M
-4.23M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more